Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Centogene N.V.
(NQ:
CNTG
)
0.3250
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.3250
Bid (Size)
0.3500 (12)
Ask (Size)
0.3730 (1)
Prev. Close
0.3250
Today's Range
0.3250 - 0.3250
52wk Range
0.2511 - 1.530
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CENTOGENE Receives Delisting Notice From Nasdaq
August 07, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
August 01, 2024
From
Centogene NV
Via
GlobeNewswire
Performance
YTD
-72.22%
-72.22%
1 Month
N/A
N/A
3 Month
-9.67%
-9.67%
6 Month
-52.21%
-52.21%
1 Year
-70.45%
-70.45%
More News
Read More
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
June 20, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
May 31, 2024
From
Centogene NV
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 16, 2024
Via
InvestorPlace
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
May 15, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
May 15, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
May 14, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
May 10, 2024
From
Centogene NV
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 19, 2024
Via
InvestorPlace
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
April 19, 2024
Via
Benzinga
CENTOGENE Receives Nasdaq Non-Compliance Notice
April 02, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
March 19, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
February 29, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
February 28, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Explores Strategic Alternatives
February 28, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
January 25, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Receives French Research Tax Credit Accreditation
January 24, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
January 23, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Preliminary Full Year 2023 Revenue
January 18, 2024
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Announces Voting Results of Extraordinary General Meeting
December 19, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
December 13, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
November 28, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
November 14, 2023
From
Centogene NV
Via
GlobeNewswire
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
October 10, 2023
From
Centogene NV
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.